PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
AXLA vs. OLMA
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between AXLA and OLMA is 0.14, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.1

Performance

AXLA vs. OLMA - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Axcella Health Inc. (AXLA) and Olema Pharmaceuticals, Inc. (OLMA). The values are adjusted to include any dividend payments, if applicable.

-60.00%-40.00%-20.00%0.00%SeptemberOctoberNovemberDecember2025February0
-60.22%
AXLA
OLMA

Key characteristics

Fundamentals

Market Cap

AXLA:

$1.18M

OLMA:

$368.99M

EPS

AXLA:

-$18.25

OLMA:

-$2.35

Returns By Period


AXLA

YTD

N/A

1M

N/A

6M

N/A

1Y

N/A

5Y*

N/A

10Y*

N/A

OLMA

YTD

-14.75%

1M

-12.19%

6M

-60.21%

1Y

-66.84%

5Y*

N/A

10Y*

N/A

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

AXLA vs. OLMA — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

AXLA

OLMA
The Risk-Adjusted Performance Rank of OLMA is 55
Overall Rank
The Sharpe Ratio Rank of OLMA is 66
Sharpe Ratio Rank
The Sortino Ratio Rank of OLMA is 55
Sortino Ratio Rank
The Omega Ratio Rank of OLMA is 77
Omega Ratio Rank
The Calmar Ratio Rank of OLMA is 66
Calmar Ratio Rank
The Martin Ratio Rank of OLMA is 11
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

AXLA vs. OLMA - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Axcella Health Inc. (AXLA) and Olema Pharmaceuticals, Inc. (OLMA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
No data
The chart of Calmar ratio for AXLA, currently valued at 0.00, compared to the broader market0.002.004.006.000.00-0.74
AXLA
OLMA


Rolling 12-month Sharpe Ratio-1.50-1.00-0.500.000.50SeptemberOctoberNovemberDecember2025February
-1.00
-0.86
AXLA
OLMA

Dividends

AXLA vs. OLMA - Dividend Comparison

Neither AXLA nor OLMA has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

AXLA vs. OLMA - Drawdown Comparison


-95.00%-90.00%-85.00%-80.00%-75.00%SeptemberOctoberNovemberDecember2025February
-97.27%
-90.88%
AXLA
OLMA

Volatility

AXLA vs. OLMA - Volatility Comparison

The current volatility for Axcella Health Inc. (AXLA) is 0.00%, while Olema Pharmaceuticals, Inc. (OLMA) has a volatility of 22.20%. This indicates that AXLA experiences smaller price fluctuations and is considered to be less risky than OLMA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


0.00%10.00%20.00%30.00%40.00%SeptemberOctoberNovemberDecember2025February0
22.20%
AXLA
OLMA

Financials

AXLA vs. OLMA - Financials Comparison

This section allows you to compare key financial metrics between Axcella Health Inc. and Olema Pharmaceuticals, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab